Skip to content
Menu

AbCellera Biologics Inc. ABCL

Full chart Compare
Set alert

Price alert · ABCL

All alert types
10.47 USD -0.55 (-4.99%)

Regular-session close

10.30 -0.17 -1.62%

After hours · Nov 19, 7:50 PM ET

10.38 Day range 11.29
2.75 52-week range 15.02
YTD
+206.14%
1 year
+190.03%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$39.51MIncome Tax Benefit$31.18MGross Profit$46.31MNet Loss$146.41MCost of Revenue$28.82MExpenses$263.41MSelling, General & Admin$76.58MResearch & Development$186.83MRevenue$75.13MLicense$46.92MResearch Fees$27.21MMilestone Payments$1.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ABCL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
75.13M28.83M38.02M485.42M375.20M
75.13M28.83M38.02M485.42M375.20M
-217.10M-314.77M-237.21M216.51M204.41M
-146.41M-162.86M-146.40M158.52M153.46M
-0.49-0.55-0.510.500.48
ABCL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
153.51M181.32M158.32M411.54M501.14M
1.36B1.36B1.49B1.54B1.32B
390.05M304.47M335.78M307.63M292.84M
137.40M60.74M71.22M76.67M36.41M
966.90M1.06B1.15B1.23B1.03B
ABCL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-131.29M-108.56M-43.88M277.36M244.58M
87.75M121.41M-221.11M-352.63M-332.25M
14.08M12.77M10.36M-1.63M-3.89M
-42.77M-78.40M-76.95M-70.66M-58.45M
-28.37M23.00M-254.04M-86.49M-92.97M